Hisoar: Development Of Double Medicine And Dye Industry Outperform Rating

Date:Jan 26, 2016

The night of January 11, the company announced, proposed by national SMEs equity trading system with their own capital to buy Chao Mr Yangzhou rixin bio-tech company limited (hereinafter "Nikko creature") 17 million shares, Ms Qiao Wenfang Nikko organisms 3 million shares, total purchase of 20 million shares, traded at 5 Yuan per share trading price of 100 million Yuan. After the transaction is completed, the company owns 18.18% shares of Nikko bio.